Mary Lou McGregor, MD :: Nationwide Children’s Hospital, Columbus, Ohio

Contact Information

555 S. 18th St
Ste 4C
Columbus, OH 43205 [ map ]
PH: (614) 224-6222
FX: (614) 241-5232

Location Information for Patients

Main Campus

Biography

Mary Lou McGregor, MD, is a member of the Department of Ophthalmology and Director of the Eye Clinic at Nationwide Children’s Hospital and a Clinical Assistant Professor of Ophthalmology at The Ohio State University College of Medicine. She is the past president of the Medical Staff at Nationwide Children’s Hospital. Her clinical interests include pediatric cataracts, strabismus, low vision and retinopathy of prematurity (ROP). She has been an investigator in several multicenter National Institutes of Health grants, including the CRYO-ROP study, STOP-ROP and the ETROP study. She is the director of the Multidisciplinary Low Vision Clinic at Nationwide Children’s Hospital. Dr. McGregor received the Makley- Battles Teaching Award in 1996. Dr. McGregor is a fellow of the American Academy of Ophthalmology and a member of the American Association for Pediatric Ophthalmology and Strabismus.

Gender:

  • Female

Languages Spoken:

  • English

Education and Training

Medical School

  • Northeastern Ohio Universities College of Medicine
    Date Completed: 05/31/1985

Internship

  • Riverside Methodist Hospital
    Date Completed: 06/30/1986

Residency

  • University Hospitals of Cleveland
    Date Completed: 06/30/1989

Fellowship

  • Nationwide Children's Hospital
    Date Completed: 06/30/1990

Fellowship

  • Moorfields Eye Hospitals - London, England
    Date Completed: 04/01/1991

Department:

  • Ophthalmology

Specialty:

  • Ophthalmology

Date of Appointment at Nationwide Children’s Hospital:

  • 02/11/1992

Publications

  • Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Tung B, Redford M, for the Early Treatment for Retinopathy of Prematurity Cooperative Group. 2010. Final visual acuity results in the early treatment for retinopathy of prematurity study.  Archives of Ophthalmology. Vol. 128, no. 6. (June 1): 663-663.
  • Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Tung B, Redford M, for the Early Treatment for Retinopathy of Prematurity Cooperative Group. 2010. Final visual acuity results in the early treatment for retinopathy of prematurity study.  Archives of Ophthalmology. Vol. 128, no. 6. (June): e663.
  • Rogers DL, Whitehead GR, Stephens JA, Fellows RR, Bremer DL McGregor ML, Golden RP, Cassady CB, Rogers GL. 2010. Corneal power measurements in fixating versus anesthetized nonfixating children using a handheld keratometer.  Journal of AAPOS. Vol. 14, no. 1. (February): e11.
  • Rogers DL, Whitehead GR, Stephens JA, Fellows RR, Bremer DL McGregor ML, Golden RP, Cassady CB, Rogers GL. 2010. Corneal power measurements in fixating versus anesthetized nonfixating children using a handheld keratometer.  Journal of AAPOS. Vol. 14, no. 1. (February 1): 11-11.
  • Repka MX, Chandler DL, Holmes JM, Hoover DL, Morse, CL, Schloff S, Silbert DI, Tien DR; Pediatric Eye Disease Investigator Group. 2009. Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing.  Archives Of Ophthalmology. Vol. 127, no. 5. (May): 633-639.
  • Repka MX, Chandler DL, Holmes JM, Hoover DL, Morse, CL, Schloff S, Silbert DI, Tien DR; Pediatric Eye Disease Investigator Group. 2009. Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing.  Archives Of Ophthalmology. Vol. 127, no. 5. (May 1): 633-639-633-639.
  • Pediatric Eye Disease Investigation Group, Repka M, Chandler DL, Bremer DL, Collins ML, Lee DH. 2009. Repeat probing for treatment of persistent nasolacrimal duct obstruction.  Journal of AAPOS. Vol. 13, no. 3. (January 1): 306-307-306-307.
  • Pediatric Eye Disease Investigator Group, Repka MX, Melia BM, Beck RW, Atkinson CS, Chandler DL, Holmes JM, Khammer A, Morrison D, Quinn GE, Silbert DI, Ticho BH, Wallce DK, Weakly DR. 2008. Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age.  Journal of AAPOS. Vol. 12, no. 5. (October): e445.
  • Pediatric Eye Dsease Investigator Group, Repka MX, Melia BM, Beck RW, Chandler DL, Fishman DR, Goldblum TA, Holmes JM, Perla BD, Quinn GE, Silbert DL, Wallace DK. 2008. Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.  Journal of AAPOS. Vol. 12, no. 5. (October): 451-455.
  • Pediatric Eye Disease Investigator Group, Repka MX, Melia BM, Beck RW, Atkinson CS, Chandler DL, Holmes JM, Khammer A, Morrison D, Quinn GE, Silbert DI, Ticho BH, Wallce DK, Weakly DR. 2008. Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age.  Journal of AAPOS. Vol. 12, no. 5. (October 1): 445-445.
  • Pediatric Eye Dsease Investigator Group, Repka MX, Melia BM, Beck RW, Chandler DL, Fishman DR, Goldblum TA, Holmes JM, Perla BD, Quinn GE, Silbert DL, Wallace DK. 2008. Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.  Journal of AAPOS. Vol. 12, no. 5. (October 1): 451-455-451-455.
  • Pediatric Eye Disease Investigator Group, Repka MX, Chandler DL, Beck RW, Crouch ER, Donahue S, Holmes M, Lee K, Melia M, Sala NA, Silbert DL, Wallace DK. 2008. Primary treatment of nasolacrimal duct obstruction with probing in children less than four years.  Ophthalmology. Vol. 115, no. 3. (January 1): 577-584-577-584.
  • Bremer DL, Hardy RJ, McClead RE, McGregor ML, Rogers GL. 2007. Retinopathy of prematurity: an optimum screening strategy.  Journal of AAPOS. Vol. 11, no. 1. (February): e68; author reply 68.
  • Bremer DL, Hardy RJ, McClead RE, McGregor ML, Rogers GL. 2007. Retinopathy of prematurity: an optimum screening strategy.  Journal of AAPOS. Vol. 11, no. 1. (February 1): 68; author reply 68-68; author reply 68.
  • Hertle RW, Scheiman MM, BEck RW, Chandler DL, Bacal DA, Birch E, Chu RH, Holmes JM, Klimak DL, Lee KA, Repka MX, Weakley DR; Pediatric Eye Disease Investigator Group. 2007. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years.  Archives of Ophthalmology. Vol. 125, no. 5. (January 1): 655-659-655-659.
  • Holmes JM, Melia M, Bradfiled YS, Cruz OA, Forbes B; Pediatric Eye Disease Investigator Group. 2007. Factors associated with recurrence of amblyopia on cessation of patching.  Ophthalmology. Vol. 114, no. 8. (January 1): 1427-1432-1427-1432.
  • Cotter SA, Edwrds AR, Arnold RW, Astle WF, Barnhardt CN, Beck RW, Birch EE, Donahue SP, Everett DF, Joost FE, Holmes JM, Kraker RT, Melia M, Repka MX, Wallace DK, Weise KK, Pediatric Eye Disease Investigator Group. 2007. Treatment of strabismic amblyopia with refractive correction.  American Journal of Ophthalmology. Vol. 143, no. 6. (January 1): 1060-1063-1060-1063.
  • Hardy RJ, Good WV, Dobson V, Palmer V, Tung B, Phelps DL, Shapiro MJ, van Heuven WJ; Early Treatment for Retinopathy of Prematurity Cooperative Group. 2006. The Early Treatment for Retinopathy of Prematurity Clinical Trial: Presentation by subgroups versus analysis within subgroups.  British Journal of Ophthalmology. Vol. 90, no. 11. (November): e1341.
  • Hardy RJ, Good WV, Dobson V, Palmer V, Tung B, Phelps DL, Shapiro MJ, van Heuven WJ; Early Treatment for Retinopathy of Prematurity Cooperative Group. 2006. The Early Treatment for Retinopathy of Prematurity Clinical Trial: Presentation by subgroups versus analysis within subgroups.  British Journal of Ophthalmology. Vol. 90, no. 11. (November 1): 1341-1341.
  • Wallace DK, Pediatric Eye Disease Investigator Group, Edwards AR, Cotter Sa, Beck RW, Astle WF, Barnhardt CN, Birch EE, Donahue SP, Felius J, Holmes JM, Kraker RT, Melia M, Repka MX, Sala NA, Silbert DI, Weises KK. 2006. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children.  Ophthalmology. Vol. 113, no. 6. (January 1): 904-912-904-912.
  • Good WV, Hardy RJ ,on behalf of the Early Treatment for Retinopathy of Prematurity Cooperative Group. 2006. Results of the Early Treatment for Retinopathy of Prematurity Study.  Molecular Vision.
  • VanderVeen DK, Coats DK, Dobson V, Fredrick D, Gordon RA, Hardy RJ, Neely DE, Palmer EA, Steidl SM, Tung B, Good EA; Early Treatment of Retinopathy of Prematurity Cooperative Group. 2006. The prevalence and course of strabismus in the first year of life for infants with prethreshold ROP: Findings from the Early Treatment of Retinopathy or Prematurity Study.  Archives of Ophthalmology. Vol. 124, no. 6. (January 1): 766-773-766-773.
  • Good W; Early Treatment for Retinopathy of Prematurity Cooperative Group. 2006. The Early Treatment for Retinopathy of Prematurity Study (ETROP): Structural Findings at 2 Years of Age.  British Journal of Ophthalmology.
  • Wallace DK, Pediatric Eye Disease Investigator Group, Edwards AR, Cotter Sa, Beck RW, Astle WF, Barnhardt CN, Birch EE, Donahue SP, Felius J, Holmes JM, Kraker RT, Melia M, Repka MX, Sala NA, Silbert DI, Weises KK. 2006. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children.  Ophthalmology. Vol. 113, no. 6. (January): 904-912.
  • Pediatric Eye Disease Investigator Group. 2006. Treatment of anisometropic amblyopia in children with refractive correction.  Ophthalmology. Vol. 13, no. 6. (January 1): 895-903-895-903.
  • Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B; Early Treatment for Retinopathy of Prematurity Cooperative Group. 2005. The incidence and course of retinopathy of prematurity: Findings from the Early Treatment for Retinopathy of Prematurity study.  Pediatrics. Vol. 116, no. 1. (July): e15.
  • Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B; Early Treatment for Retinopathy of Prematurity Cooperative Group. 2005. The incidence and course of retinopathy of prematurity: Findings from the Early Treatment for Retinopathy of Prematurity study.  Pediatrics. Vol. 116, no. 1. (July 1): 15-15.
  • Scheiman MM, Hertle RW, Beck RW, Edwards AR, Birch E, Cotter SA, Crouch ER, Cruz OA, David BV, Donahue SP, Holmes JM, Lyon DW, Repka MX, Sala NA, Silbert DI, Suh DW, Tamkins SM; Pediatric Eye Disease Investigator Group. 2005. Randomized trial of treatment of amblyopia in children 7 to 17 Years.  Archives of Ophthalmology. Vol. 123, no. 4. (January 1): 437-447-437-447.
  • Palmer EA, Hardy RJ, Dobson V, Phelps V, Quinn GE, Summers GC, Krom CP, Tung B; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 2005. Fifteen year outcomes following threshold retinopathy of prematurity: Final results from the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity.  Archives of Ophthalmology. Vol. 123, no. 3. (January 1): 311-318-311-318.
  • Quinn GE, Dobson V, Saigal S, Phelps DL, Hardy RJ, Tung B, Summers CG, Palmer EA; Cryotherapy for Retinopathy of Prematurity Cooperative Subgroup. 2004. Health-related quality of life at age 10 years in very low-birth-weight children with and without threshold retinopathy of prematurity.  Archives Of Ophthalmology. Vol. 122, no. 11. (November): e1659.
  • Quinn GE, Dobson V, Saigal S, Phelps DL, Hardy RJ, Tung B, Summers CG, Palmer EA; Cryotherapy for Retinopathy of Prematurity Cooperative Subgroup. 2004. Health-related quality of life at age 10 years in very low-birth-weight children with and without threshold retinopathy of prematurity.  Archives Of Ophthalmology. Vol. 122, no. 11. (November 1): 1659-1659.
  • Msall ME, Phelps DL, Hardy RJ, Dobson V, Quinn GE, Summers CG, Tremont MR; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 2004. Educational and social competencies at 8 years in children with threshold retinopathy of prematurity in the CRYO-ROP multicenter study.  Pediatrics. Vol. 113, no. 4. (January): e790.
  • Good WV, and on behalf of the Early Treatment for Retinopathy of Prematurity Cooperative Group. 2004. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.  Transactions of the American Ophthalmological Society. Vol. 102, no. January 1: 233-233.
  • Msall ME, Phelps DL, Hardy RJ, Dobson V, Quinn GE, Summers CG, Tremont MR; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 2004. Educational and social competencies at 8 years in children with threshold retinopathy of prematurity in the CRYO-ROP multicenter study.  Pediatrics. Vol. 113, no. 4. (January 1): 790-790.
  • Hardy RJ, Good WV, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B; Early Treatment for Retinopathy of Prematurity Cooperative Group. 2004. Multicenter Trial of Early Treatment for Retinopathy of Prematurity: Study design.  Controlled Clinical Trials. Vol. 25, no. 3. (January 1): 311-325-311-325.
  • Pediatric Eye Disease Investigator Group. 2004. Risk of amblyopia recurrence after cessation of treatment.  Journal of AAPOS. Vol. 8, no. 5. (January 1): 420-428-420-428.
  • Siatkowski RM, Cotter S, Miller JM, Scher CA, Crockett RS, Novack GD; US Pirenzepine Study Group. 2004. Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia.  Archives of Ophthalmology. Vol. 122, no. 11. (January 1): 1667-1674-1667-1674.
  • Quinn GE, Beck RW, Holmes JM, Repka MX; Pediatric Eye Disease Investigator Group. 2004. Recent advances in the treatment of amblyopia.  Pediatrics. Vol. 133, no. 6. (January 1): 1800-1802-1800-1802.
  • Good WV, and on behalf of the Early Treatment for Retinopathy of Prematurity Cooperative Group. 2004. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.  Transactions of the American Ophthalmological Society. Vol. 102, no. January: e233.
  • Phelps DL; Early Treatment for Retinopathy of Prematurity Cooperative Group. 2004. The Early Treatment for Retinopathy of Prematurity Study: Better outcomes, changing strategy.  Pediatrics. Vol. 114, no. 2. (January 1): 490-491-490-491.
  • 2003. Retinal hemorrhage asymmetry in inflicted head injury: a clue to pathogenesis?.  J Pediatr. Vol. 143, no. 4. (October 1).
  • Good W, and on behalf of for Early Treatment for Retinopathy of Prematurity Cooperative Group. 2003. Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial.  Archives of Ophthalmology. Vol. 121, no. 12. (January 1): 1684-1696-1684-1696.
  • Holmes JM, Beck RW, Kraker RT, Cole SR, Repka MX, Birch EE, Felius J, Christiansen SP, Coats DK, Kulp MT; Pediatric Eye Disease Investigator Group. 2003. Impact of patching and atropine treatment on the child and family in the Amblyopia Treatment Study.  Archives of Ophthalmology. Vol. 121, no. 11. (January 1): 1625-1632-1625-1632.
  • Good W, and on behalf of for Early Treatment for Retinopathy of Prematurity Cooperative Group. 2003. Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial.  Archives of Ophthalmology. Vol. 121, no. 12. (January): 1684-1696.
  • Holmes JM, Kraker RT, Beck RW, Birch EE, Cotter SA, Everett DF, Hertle RW, Quinn GE, Repka MX, Scheiman MM, Wallace DK; Pediatric Eye Disease Investigator Group. 2003. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children.  Ophthalmology. Vol. 110, no. 11. (January 1): 2075-2087-2075-2087.
  • Gilles E, McGregor ML, Levy-Clarke G. 2003. Retinal hemorrhage asymmetry in inflicted head injury: A clue to pathogenesis?.  Journal of Pediatrics. Vol. 143, no. 4. (January): 494-499.
  • McGregor ML, Bremer DL, Cole C, McClead RE, Phelps DL, Fellows RR, Oden N, on behalf of the HOPE-ROP Multicenter Group. 2002. Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study.  Pediatrics. Vol. 110, no. 3. (September 1): 540-540.
  • McGregor ML, Bremer DL, Cole C, McClead RE, Phelps DL, Fellows RR, Oden N, on behalf of the HOPE-ROP Multicenter Group. 2002. Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study.  Pediatrics. Vol. 110, no. 3. (September): e540.
  • Pediatric Eye Disease Investigator Group. 2002. Spontaneous resolution of early-onset esotropia: experience of the Congenital Esotropia Observational Study.  American Journal of Ophthalmology. Vol. 133, no. 1. (January 1): 109-118-109-118.
  • Palmer EA, Hardy RH, Dobson V, Phelps DL, Quinn GE, Summers G, Tung B; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 2002. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Natural history ROP: Ocular outcomes at 5 ½ years in premature infants with birth weights less than 1251 grams.  Archives of Ophthalmology. Vol. 120, no. January 1: 595-599-595-599.
  • Pediatric Eye Disease Investigator Group. 2002. The clinical spectrum of early-onset esoptropia: experience of the Congenital Esotropia Observational Study.  American Journal of Ophthalmology. Vol. 133, no. 1. (January 1): 102-108-102-108.
  • Quinn GE, Dobson V, Siatkowski R, Hardy Rj, Kivlin J, Palmer EA, Phelps D, Repka MX, Sumers G, Tung B; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 2001. Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial.  Ophthalmology. Vol. 108, no. 2. (February): e343.
  • Quinn GE, Dobson V, Siatkowski R, Hardy Rj, Kivlin J, Palmer EA, Phelps D, Repka MX, Sumers G, Tung B; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 2001. Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial.  Ophthalmology. Vol. 108, no. 2. (February 1): 343-343.
  • Cryotherapy for Retinopathy of Prematurity Cooperative Group. 2001. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Ophthalmological outcomes at ten years.  Archives of Ophthalmology. Vol. 119, no. 8. (January 1): 1110-1118-1110-1118.
  • Msall ME, Phelps DL, DiGaudio KM, Dobson V, Tung B, McClead R, Quinn G, Reynolds JD, Hardy RJ, Palmer EA. 2000. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Pediatrics. Vol. 106, no. 5. (November): e998.
  • Msall ME, Phelps DL, DiGaudio KM, Dobson V, Tung B, McClead R, Quinn G, Reynolds JD, Hardy RJ, Palmer EA. 2000. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Pediatrics. Vol. 106, no. 5. (November 1): 998-998.
  • Repka MX, Palmer EA, Tung B; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 2000. Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Archives Of Ophthalmology. Vol. 118, no. 5. (May 1): 645-645.
  • Repka MX, Palmer EA, Tung B; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 2000. Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Archives Of Ophthalmology. Vol. 118, no. 5. (May): e645.
  • McClead RE, McGregor ML, Bremer D, Cole C. Fellows R, Phelps D, Oden N; HOPE-ROP Study Group. 2000. HOPE ROP (high oxygen percentage in retinopathy of prematurity) study: Rop outcome in infants with prethreshold Rop and Spo2> 94% in room air.  Pediatric Research. Vol. 47, no. 4 Part 2. (January): e415A.
  • McClead RE, McGregor ML, Bremer D, Cole C. Fellows R, Phelps D, Oden N; HOPE-ROP Study Group. 2000. HOPE ROP (high oxygen percentage in retinopathy of prematurity) study: Rop outcome in infants with prethreshold Rop and Spo2> 94% in room air.  Pediatric Research. Vol. 47, no. 4 Part 2. (January 1): 415A-415A.
  • The STOP-ROP Multicenter Study Group. 2000. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes.  Pediatrics. Vol. 105, no. 2. (January 1): 295-310-295-310.
  • McGregor ML, Fellows RR. 2000. Treating Visual Impairment.  Directions. Vol. 1, no. 10. (January 1): 10-13-10-13.
  • Dobson V, Quinn GE, Siatkowski RM, Baker JD, Hardy RJ, Reynolds JD, Trese MT, Tung B; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1999. Agreement between grating acuity at age 1 year and Snellen acuity at age 5.5 years in the preterm child.  Investigative Ophthalmology & Visual Science. Vol. 40, no. 2. (February): e496.
  • Dobson V, Quinn GE, Siatkowski RM, Baker JD, Hardy RJ, Reynolds JD, Trese MT, Tung B; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1999. Agreement between grating acuity at age 1 year and Snellen acuity at age 5.5 years in the preterm child.  Investigative Ophthalmology & Visual Science. Vol. 40, no. 2. (February 1): 496-496.
  • Rogers AH, Rogers GL, Bremer DL, McGregor ML. 1999. Pseudotumor cerebri in children receiving recombinant human growth hormone.  Ophthalmology. Vol. 106, no. 6. (January): 1186-1190.
  • Harvey EM, Dobson V, Tung B, Quinn GE, Hardy RJ; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1999. Interobserver agreement for grating acuity and letter acuity assessment in 1-to 5.5-year olds with severe retinopathy of prematurity.  Investigative Ophthalmology & Visual Science. Vol. 40, no. 7. (January 1): 1565-1576-1565-1576.
  • Rogers AH, Rogers GL, Bremer DL, McGregor ML. 1999. Pseudotumor cerebri in children receiving recombinant human growth hormone.  Ophthalmology. Vol. 106, no. 6. (January 1): 1186-1190-1186-1190.
  • McGregor ML,Wherley AJ, Fellows RR, Bremer DL, Rogers GL, Letson AD. 1998. A comparison of cryotherapy versus diode laser retinopexy in 100 consecutive infants treated for threshold retinopathy of prematurity.  Journal of AAPOS. Vol. 2, no. 6. (December): e360.
  • McGregor ML,Wherley AJ, Fellows RR, Bremer DL, Rogers GL, Letson AD. 1998. A comparison of cryotherapy versus diode laser retinopexy in 100 consecutive infants treated for threshold retinopathy of prematurity.  Journal of AAPOS. Vol. 2, no. 6. (December 1): 360-360.
  • Birch E, Stager D, Wright K, Beck R; Pediatric Eye Disease Investigator Group. 1998. The natural history of infantile esotropia during the first six months of life.  Journal of AAPOS. Vol. 2, no. 6. (December 1): 325-328, discussion 329-325-328, discussion 329.
  • Leguire LE, Rogers GL, Walson PD, Bremer DL, McGregor ML. 1998. Occlusion and levodopa-carbidopa treatment for childhood amblyopia.  Journal of AAPOS. Vol. 2, no. 5. (October): e257.
  • Leguire LE, Rogers GL, Walson PD, Bremer DL, McGregor ML. 1998. Occlusion and levodopa-carbidopa treatment for childhood amblyopia.  Journal of AAPOS. Vol. 2, no. 5. (October 1): 257-257.
  • Repka MX, Summers CG, Palmer EA, Dobson V, Tung B, Davis B; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1998. The incidence of ophthalmologic interventions in children with birth weights less than 1251 grams. Results through 5 1/2 years. Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Ophthalmology. Vol. 105, no. 9. (September): e1621.
  • Repka MX, Summers CG, Palmer EA, Dobson V, Tung B, Davis B; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1998. The incidence of ophthalmologic interventions in children with birth weights less than 1251 grams. Results through 5 1/2 years. Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Ophthalmology. Vol. 105, no. 9. (September 1): 1621-1621.
  • Leguire LE, Jende DL, Nairus TM, Walson PD, Rogers GL, Bremer DL, McGregor ML. 1998. Levodopa-carbidopa and childhood retinal disease.  Journal of AAPOS. Vol. 2, no. 2. (April): e79.
  • Leguire LE, Jende DL, Nairus TM, Walson PD, Rogers GL, Bremer DL, McGregor ML. 1998. Levodopa-carbidopa and childhood retinal disease.  Journal of AAPOS. Vol. 2, no. 2. (April 1): 79-79.
  • 1998. Strabismus in premature infants in the first year of life.  ARCHIVES OF OPHTHALMOLOGY. Vol. 116, no. 3. (March 1).
  • Bremer DL, Palmer EA, Fellows RR, Baker JD, Hardy RJ, Tung B, Rogers GL; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1998. Strabismus in premature infants in the first year of life.  Archives Of Ophthalmology. Vol. 116, no. 3. (March): e329.
  • McGregor ML. 1998. Cataracts and Intraocular Lens Implants.  Directions. Vol. Fall/Winter, no. January 1: 20-23-20-23.
  • Quinn GE, Dobson V, Kivlin J, Kaufman LM, Repka MX, Reynolds JD, Gordon RA, Hardy RJ, Tung B, Stone RA; Cryotherapy for the Retinopathy of Prematurity Cooperative Group. 1998. Prevalence of myopia between 3 months and 5 ½ years in preterm infants with and without retinopathy of prematurity.  Ophthalmology. Vol. 105, no. January 1: 1292-1300-1292-1300.
  • Hardy RJ, Palmer EA, Schaffer DB, Phelps DL, Davis BR, Cooper CJ; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1997. Outcome-based management of retinopathy of prematurity.  Journal of AAPOS. Vol. 1, no. 1. (January 1): 46-54-46-54.
  • Quinn GE, Dobson V, Hardy RJ, Tung B, Phelps DL, Palmer EA; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1996. Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity from the cryotherapy for retinopathy of prematurity trial.  Ophthalmology. Vol. 103, no. 9. (September 1): 1432-1432.
  • Quinn GE, Dobson V, Hardy RJ, Tung B, Phelps DL, Palmer EA; Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1996. Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity from the cryotherapy for retinopathy of prematurity trial.  Ophthalmology. Vol. 103, no. 9. (September): e1432.
  • 1996. Multicenter trial of cryotherapy for retinopathy of prematurity - Snellen visual acuity and structural outcome at 5 1/2 years after randomization.  ARCHIVES OF OPHTHALMOLOGY. Vol. 114, no. 4. (April 1).
  • Kivlin JD, Biglan AW, Gordon RA, Dobson V, Hardy RA, Palmer EA, Tung B, Gilbert W, Spencer R, Cheng K, Buckley E. 1996. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Archives Of Ophthalmology. Vol. 114, no. 2. (February 1): 150-150.
  • Kivlin JD, Biglan AW, Gordon RA, Dobson V, Hardy RA, Palmer EA, Tung B, Gilbert W, Spencer R, Cheng K, Buckley E. 1996. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.  Archives Of Ophthalmology. Vol. 114, no. 2. (February): e150.
  • Leguire LE, Walson PD, Rogers GL, Bremer DL, McGregor ML. 1995. Levodopa/carbidopa treatment for amblyopia in older children.  Journal of Pediatric Ophthalmology and Strabismus. Vol. 32, no. 3. (May 1): 143-143.
  • Leguire LE, Walson PD, Rogers GL, Bremer DL, McGregor ML. 1995. Levodopa/carbidopa treatment for amblyopia in older children.  Journal of Pediatric Ophthalmology and Strabismus. Vol. 32, no. 3. (May): e143.
  • 1995. LEVODOPA CARBIDOPA TREATMENT FOR AMBLYOPIA IN OLDER CHILDREN.  JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS. Vol. 32, no. 3. (May 1).
  • Dobson V, Quinn GE, Tung B, Palmer EA, Reynolds JD; Cyrotherapy for Retinopathy of Prematurity Cooperative Group. 1995. Comparison of recognition and grating acuities in very-low-birth-weight children with and without retinal residua of retinopathy of prematurity.  Investigative Ophthalmology & Visual Science. Vol. 36, no. 3. (March): e692.
  • Dobson V, Quinn GE, Tung B, Palmer EA, Reynolds JD; Cyrotherapy for Retinopathy of Prematurity Cooperative Group. 1995. Comparison of recognition and grating acuities in very-low-birth-weight children with and without retinal residua of retinopathy of prematurity.  Investigative Ophthalmology & Visual Science. Vol. 36, no. 3. (March 1): 692-692.
  • Mary McGregor. 1995. Havener's Ocular Parmacology. In Adrenergic Agonists (Sympathomimetics).
  • Mary McGregor. 1995. Havener's Ocular Pharmacology. In Mosby-Year Book, Inc..
  • Mary McGregor. 1995. Havener's Ocular Pharmacology. In Mosby-Year Book, Inc..
  • Mary McGregor. 1995. Havener's Ocular Parmacology. In Adrenergic Agonists (Sympathomimetics).
  • Mary McGregor. 1995. Havener's Ocular Pharmacology. In Mosby-Year Book, Inc..
  • Mary McGregor. 1995. Havener's Ocular Pharmacology. In Mosby-Year Book, Inc..
  • Mary McGregor. 1995. Havener's Ocular Pharmacology. In Mosby-Year Book, Inc..
  • Mary McGregor. 1995. Havener's Ocular Pharmacology. In Mosby-Year Book, Inc..
  • Fellows RR, McGregor ML, Bremer DL, Rogers GL, Miller D. 1995. Retinopathy of prematurity in discordant twins.  Journal of Pediatric Ophthalmology and Strabismus. Vol. 32, no. 2. (January 1): 86-88-86-88.
  • Quinn GE, Dobson V, Biglan A, Evans J, Plotsky D, Hardy RJ; for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1995. Correlation of retinopathy of prematurity in fellow eyes in the CRYO-ROP Study.  Archives of Ophthalmology. Vol. 113, no. 4. (January 1): 469-473-469-473.
  • Dobson V, Quinn GE, Summers CG, Saunders SA, Phelps DL, Tung B, Palmer EA; for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1994. Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant.  Investigative Ophthalmology & Visual Science. Vol. 35, no. 13. (December): e4236.
  • Dobson V, Quinn GE, Summers CG, Saunders SA, Phelps DL, Tung B, Palmer EA; for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1994. Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant.  Investigative Ophthalmology & Visual Science. Vol. 35, no. 13. (December 1): 4236-4236.
  • McGregor ML. 1994. Adrenergic Agonists (Sympathomimetics). In Havener’s Ocular Pharmacology. Edited by Mauger, T., Craig EL (ed).
  • Mary McGregor. 1994. Duane's Clinical Ophthalmology. In Pediatric Ocular Trauma.
  • McGregor ML. 1994. Anticholinergic Agents (Parasympatholytics). In Havener’s Ocular Pharmacology. Edited by Mauger T, Craig EL (ed).
  • Mary McGregor. 1994. Duane's Clinical Ophthalmology. In Pediatric Ocular Trauma.
  • McGregor ML. 1994. Adrenergic Agonists (Sympatholytics). In Havener’s Ocular Pharmacology. Edited by Mauger T, Craig EL (ed).
  • Cahill KV and McGregor ML. 1994. Biologic Drugs. In Havener’s Ocular Pharmacology. Edited by Mauger T, Craig EL (ed).
  • Rogers GL, Bremer DL , McGregor ML. 1994. Pediatric Ocular Trauma. In Duane’s Clinical Ophthalmology. Edited by Tashman W, Jaeger, EA (eds).
  • Leguire LE, Walson PD, Rogers GL, Bremer DL, McGregor ML. 1993. Longitudinal study of levodopa/carbidopa for childhood amblyopia.  Journal of Pediatric Ophthalmology and Strabismus. Vol. 30, no. 6. (November): e354.
  • Leguire LE, Walson PD, Rogers GL, Bremer DL, McGregor ML. 1993. Longitudinal study of levodopa/carbidopa for childhood amblyopia.  Journal of Pediatric Ophthalmology and Strabismus. Vol. 30, no. 6. (November 1): 354-354.
  • Leguire LE, Rogers GL, Bremer DL, Walson PD, McGregor ML. 1993. Levodopa/carbidopa for childhood amblyopia.  Investigative Ophthalmology & Visual Science. Vol. 34, no. 11. (October 1): 3090-3090.
  • Leguire LE, Rogers GL, Bremer DL, Walson PD, McGregor ML. 1993. Levodopa/carbidopa for childhood amblyopia.  Investigative Ophthalmology & Visual Science. Vol. 34, no. 11. (October): e3090.
  • Dobson V, Quinn GE, Flynn J, Gilbert W, Hardy RJ, Phelps DL, Palmer EA; for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. 1993. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: 3½ year outcome-structure and function.  Archives of Ophthalmology. Vol. 111, no. 3. (January 1): 339-344-339-344.
  • Leguire LE, Pappa KS, McGregor ML, Rogers GL, Bremer DL. 1992. Electro-oculogram in vitamin A deficiency associated with cystic fibrosis. Short communication.  Ophthalmic Paediatrics and Genetics. Vol. 13, no. 3. (September): e187.
  • Leguire LE, Pappa KS, McGregor ML, Rogers GL, Bremer DL. 1992. Electro-oculogram in vitamin A deficiency associated with cystic fibrosis. Short communication.  Ophthalmic Paediatrics and Genetics. Vol. 13, no. 3. (September 1): 187-187.
  • Leguire LE, Pappa KS, Kachmer ML, Rogers GL, Bremer DL. 1991. Loss of contrast sensitivity in cystic fibrosis.  American Journal of Ophthalmology. Vol. 111, no. 4. (April 1): 427-427.
  • Leguire LE, Pappa KS, Kachmer ML, Rogers GL, Bremer DL. 1991. Loss of contrast sensitivity in cystic fibrosis.  American Journal of Ophthalmology. Vol. 111, no. 4. (April): e427.
  • Annable W, Kachmer ML, Dimarco M, DiSantis D. 1990. Long-term follow-up of Candida endophthalmitis in the premature infant.  Journal of Pediatric Ophthalmology and Strabismus. Vol. 27, no. 2. (March 1): 103-106-103-106.
  • Kachmer ML, Annable W, DiMarco M. 1990. Iritis in children with varicella.  Journal of Pediatric Ophthalmology and Strabismus. Vol. 27, no. 4. (January 1): 221-222-221-222.
  • 1989. Comparison of corneal storage in K-Sol and chondroitin sulfate corneal storage medium in human corneal transplantation.  Ophthalmology. Vol. 96, no. 5. (May 1).
  • 1988. The latest on retinopathy of prematurity.  MCN. The American journal of maternal child nursing. Vol. 13, no. 4. (July 1).
  • Bremer DL, Hardy RJ, McClead RE, McGregor ML, Rogers GL. Retinopathy of prematurity: an optimum screening strategy. Journal of AAPOS 11(1): 68 (author reply), February 2007.

Awards, Honors and Organizations

  • Listed, Best Doctors in America
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000